{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:32:07Z","timestamp":1790857927997,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T00:00:00Z","timestamp":1099526400000},"content-version":"vor","delay-in-days":2621,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[1997,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Levodopa (LD) is the most effective drug for symptomatic control of Parkinson's disease, but has been suspected to be toxic to substantia nigra (SN) dopaminergic neurons. Tissue culture and animal studies of LD toxicity have produced contradictory evidence, and one study reported that a human subject exposed to a large cumulative dose (ed) of LD over 4 years had no evidence of SN damage. We reprot the cases of five patients, each of whom received a large cd of LD over a long period. Fluorodopa positron\u2010emission tomography performed in one case indicated parkinsonism. Autopsies in two cases indicated a normal SN in one and a hypopigmented SN with normal cell complement in the other. Three patients had essential tremor, one had nonprogressive parkinsonism, and one had dopa\u2010responsive dystonia. LD (without decarboxylase inhibitor) was administered over 21 years (cd = 21.99 kg), 9 years (cd = 6.6 kg), 26 years (cd = 18.7 kg), 11 years (cd = 3 kg), and 26 years (cd = 23.93 kg), respectively. None of the patients with essential tremor developed clinical features of parkinsonism that indicated significant SN damage, and one had a normal SN at autopsy. The parkinsonian patient displayed no detectable acceleration of disease process, and the patient with dopa\u2010responsive dystonia had a normal complement of SN neurons at autopsy. We conclude that LD, administered at a dose commonly used for treating Parkinson's disease, was not toxic to SN neurons in these cases.<\/jats:p>","DOI":"10.1002\/mds.870120503","type":"journal-article","created":{"date-parts":[[2005,5,28]],"date-time":"2005-05-28T20:28:34Z","timestamp":1117312114000},"page":"634-638","source":"Crossref","is-referenced-by-count":90,"title":["Is levodopa toxic to human substantia nigra?"],"prefix":"10.1002","volume":"12","author":[{"given":"A. H.","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Birdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Macaulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,11,4]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"787","article-title":"The effect of l\u2010d, 4\u2010hydroxyphenylalanine (=DOPA) on akinesia in Parkinsonism","volume":"73","author":"Birkmayer W","year":"1961","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_2_1_3_2","first-page":"802","article-title":"The pathogenesis of Parkinson's disease: a new hypothesis","volume":"87","author":"Barbeau A","year":"1962","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196702162760703"},{"key":"e_1_2_1_5_2","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Homykiewicz O","year":"1987","journal-title":"Adv Neurol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199012000-00007"},{"key":"e_1_2_1_7_2","first-page":"175","article-title":"The pathology of parkinsonism: a comparison of degenerations in cerebral cortex and brainstem","volume":"5","author":"Alvord EC","year":"1974","journal-title":"Adv Neurol"},{"key":"e_1_2_1_8_2","first-page":"124","volume-title":"Movement disorders 2","author":"Jellinger K","year":"1987"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.5.746"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64020825.x"},{"key":"e_1_2_1_11_2","first-page":"110","article-title":"Turnover of dopamine in the brain of normal and Parkinsonian patients","volume":"23","author":"Bernheimer H","year":"1966","journal-title":"Wien Z Nervenheilked Grenzgebeite"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320616"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00341-M"},{"key":"e_1_2_1_14_2","first-page":"242","article-title":"Degeneration of dopaminernic neurons and free radicals: possible participation of levodopa","volume":"60","author":"Ogawa N","year":"1993","journal-title":"Adv Neurol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870080202"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870070105"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340515"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360512"},{"key":"e_1_2_1_19_2","first-page":"18","article-title":"Reproducibility of fluorine\u2010 18\u20136\u2010flurodopa positron emission tomography in normal human subjects","volume":"35","author":"Vingerhoets FJG","year":"1994","journal-title":"J Nucl Med"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100302"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100314"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870010109"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.8.991"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"e_1_2_1_25_2","unstructured":"RajputA KishoreA SnowB BoltonCF RajputAH.Doparesponsive\u2010non\u2010progressive juvenile parkinsonism: report of a case. Mov Disord1996(in press)."},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350405"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb13642.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490260405"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.9.1194"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1984.tb12834.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90420-S"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360104"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410210409"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.49.8.853"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91006-V"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92989-F"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1982.00510220042009"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320502"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.2_Part_1.174"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.870120503","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.870120503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T13:09:34Z","timestamp":1760965774000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.870120503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.1002\/mds.870120503"],"URL":"https:\/\/doi.org\/10.1002\/mds.870120503","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}